CLINICAL_TRIALS
trial_result
· 2019-10-16
Clinical Trial Update: Multiple Treatment Session Study to Assess GSK2398852 Administered Following and Along With GSK2315698 [Phase 2]
Summary
Phase 2 trial update for a study evaluating GSK2398852 with GSK2315698 in amyloidosis has been terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Amyloidosis | Phase 2 | Status: TERMINATED | Results posted: 2019-10-16